Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
536 | 14793 | 47.6 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
269 | 3 | CELL BIOLOGY//CAVEOLIN 1//CAVEOLAE | 44007 |
536 | 2 | X LINKED AGAMMAGLOBULINEMIA//BTK//SH2 DOMAIN | 14793 |
1558 | 1 | RHO GTPASES//TIAM1//RHOB | 2595 |
5678 | 1 | PI3K GAMMA//PHOSPHOINOSITIDE 3 KINASE//P110 DELTA | 1590 |
8654 | 1 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK | 1231 |
9406 | 1 | INSULIN RECEPTOR SUBSTRATE//INSULIN RECEPTOR SUBSTRATE 1//IRS 1 | 1158 |
9431 | 1 | C ABL//BCR ABL//RIN1 | 1156 |
11502 | 1 | PAK1//P21 ACTIVATED KINASE//PAK4 | 977 |
12290 | 1 | SH3 DOMAIN//SH2 DOMAIN//GRB2 | 917 |
13570 | 1 | NEDD9//CRK//CRKL | 828 |
13788 | 1 | SLP 76//ADAP//SECT LYMPHOCYTE SIGNALING | 813 |
14390 | 1 | CBL//CBL B//C CBL | 772 |
14683 | 1 | SHIP2//SHIP1//DOK | 756 |
17831 | 1 | P66SHC//SHC//SHC FAMILY | 580 |
18972 | 1 | SYK//SPLEEN TYROSINE KINASE//FOSTAMATINIB | 528 |
21034 | 1 | GRB7//GRB14//GRB10 | 436 |
22654 | 1 | VAV//VAV1//VAV PROTO ONCOGENE | 373 |
36304 | 1 | SWAP 70//SWITCH ASSOCIATED PROTEIN 70//DEF6 | 83 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | X LINKED AGAMMAGLOBULINEMIA | authKW | 160605 | 1% | 70% | 112 |
2 | BTK | authKW | 150439 | 1% | 61% | 119 |
3 | SH2 DOMAIN | authKW | 145476 | 1% | 45% | 157 |
4 | BRUTONS TYROSINE KINASE | authKW | 127345 | 1% | 67% | 92 |
5 | RHO GTPASES | authKW | 126208 | 2% | 25% | 248 |
6 | P66SHC | authKW | 125510 | 1% | 66% | 92 |
7 | RAC | authKW | 104724 | 1% | 28% | 184 |
8 | GRB2 | authKW | 94473 | 1% | 42% | 109 |
9 | SH3 DOMAIN | authKW | 90397 | 1% | 31% | 144 |
10 | PAK1 | authKW | 88532 | 1% | 56% | 77 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 48264 | 30% | 1% | 4441 |
2 | Biochemistry & Molecular Biology | 40118 | 44% | 0% | 6536 |
3 | Oncology | 9018 | 15% | 0% | 2153 |
4 | Immunology | 7816 | 13% | 0% | 1866 |
5 | Hematology | 3220 | 5% | 0% | 782 |
6 | Biophysics | 2697 | 6% | 0% | 882 |
7 | Genetics & Heredity | 2413 | 7% | 0% | 993 |
8 | Medicine, Research & Experimental | 1078 | 4% | 0% | 649 |
9 | Endocrinology & Metabolism | 936 | 4% | 0% | 644 |
10 | Chemistry, Medicinal | 524 | 3% | 0% | 379 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RAYMOND BEVERLY SACKLER GENET MOL MED | 32469 | 0% | 75% | 21 |
2 | LYMPHOCYTE SIGNALLING DEV | 30123 | 0% | 30% | 49 |
3 | CELL ADHES UNIT | 24981 | 0% | 61% | 20 |
4 | INOSITIDE | 16322 | 0% | 25% | 32 |
5 | LYMPHOCYTE SIGNALING DEV | 14704 | 0% | 36% | 20 |
6 | IMMUNOL | 13404 | 5% | 1% | 749 |
7 | MOL IMMUNOL PROGRAMME | 13277 | 0% | 32% | 20 |
8 | INFLAMMATORY CELL BIOL | 12844 | 0% | 69% | 9 |
9 | SECT LYMPHOCYTE SIGNALING | 11224 | 0% | 78% | 7 |
10 | CORE IL HLTH SCI | 10311 | 0% | 100% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF BIOLOGICAL CHEMISTRY | 32808 | 11% | 1% | 1592 |
2 | ONCOGENE | 29482 | 3% | 3% | 514 |
3 | MOLECULAR AND CELLULAR BIOLOGY | 22369 | 3% | 2% | 499 |
4 | CELLULAR SIGNALLING | 13408 | 1% | 4% | 170 |
5 | JOURNAL OF IMMUNOLOGY | 6673 | 3% | 1% | 437 |
6 | BLOOD | 4838 | 2% | 1% | 298 |
7 | CELL COMMUNICATION AND SIGNALING | 3948 | 0% | 7% | 27 |
8 | SCIENCE SIGNALING | 3796 | 0% | 4% | 54 |
9 | IMMUNITY | 3707 | 1% | 2% | 80 |
10 | EMBO JOURNAL | 3390 | 1% | 1% | 175 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | X LINKED AGAMMAGLOBULINEMIA | 160605 | 1% | 70% | 112 | Search X+LINKED+AGAMMAGLOBULINEMIA | Search X+LINKED+AGAMMAGLOBULINEMIA |
2 | BTK | 150439 | 1% | 61% | 119 | Search BTK | Search BTK |
3 | SH2 DOMAIN | 145476 | 1% | 45% | 157 | Search SH2+DOMAIN | Search SH2+DOMAIN |
4 | BRUTONS TYROSINE KINASE | 127345 | 1% | 67% | 92 | Search BRUTONS+TYROSINE+KINASE | Search BRUTONS+TYROSINE+KINASE |
5 | RHO GTPASES | 126208 | 2% | 25% | 248 | Search RHO+GTPASES | Search RHO+GTPASES |
6 | P66SHC | 125510 | 1% | 66% | 92 | Search P66SHC | Search P66SHC |
7 | RAC | 104724 | 1% | 28% | 184 | Search RAC | Search RAC |
8 | GRB2 | 94473 | 1% | 42% | 109 | Search GRB2 | Search GRB2 |
9 | SH3 DOMAIN | 90397 | 1% | 31% | 144 | Search SH3+DOMAIN | Search SH3+DOMAIN |
10 | PAK1 | 88532 | 1% | 56% | 77 | Search PAK1 | Search PAK1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KING, H , NICHOLAS, NS , WELLS, CM , (2014) ROLE OF P-21-ACTIVATED KINASES IN CANCER PROGRESSION.INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 309. VOL. 309. ISSUE . P. 347 -387 | 179 | 85% | 19 |
2 | KUMAR, R , LI, DQ , (2016) PAKS IN HUMAN CANCER PROGRESSION: FROM INCEPTION TO CANCER THERAPEUTIC TO FUTURE ONCOBIOLOGY.ADVANCES IN CANCER RESEARCH, VOL 130. VOL. 130. ISSUE . P. 137 -209 | 189 | 64% | 4 |
3 | FELLER, SM , (2001) CRK FAMILY ADAPTORS - SIGNALLING COMPLEX FORMATION AND BIOLOGICAL ROLES.ONCOGENE. VOL. 20. ISSUE 44. P. 6348 -6371 | 227 | 64% | 319 |
4 | SWAMINATHAN, G , TSYGANKOV, AY , (2006) THE CBL FAMILY PROTEINS: RING LEADERS IN REGULATION OF CELL SIGNALING.JOURNAL OF CELLULAR PHYSIOLOGY. VOL. 209. ISSUE 1. P. 21-43 | 201 | 65% | 164 |
5 | KUMAR, R , SANAWAR, R , LI, XD , LI, F , (2017) STRUCTURE, BIOCHEMISTRY, AND BIOLOGY OF PAK KINASES.GENE. VOL. 605. ISSUE . P. 20 -31 | 164 | 73% | 0 |
6 | SENAPEDIS, W , CROCHIERE, M , BALOGLU, E , LANDESMAN, Y , (2016) THERAPEUTIC POTENTIAL OF TARGETING PAK SIGNALING.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 16. ISSUE 1. P. 75 -88 | 145 | 67% | 3 |
7 | MOHAMED, AJ , YU, L , BACKESJO, CM , VARGAS, L , FARYAL, R , AINTS, A , CHRISTENSSON, B , BERGLOF, A , VIHINEN, M , NORE, BF , ET AL (2009) BRUTON'S TYROSINE KINASE (BTK): FUNCTION, REGULATION, AND TRANSFORMATION WITH SPECIAL EMPHASIS ON THE PH DOMAIN.IMMUNOLOGICAL REVIEWS. VOL. 228. ISSUE . P. 58 -73 | 129 | 82% | 132 |
8 | RADU, M , SEMENOVA, G , KOSOFF, R , CHERNOFF, J , (2014) PAK SIGNALLING DURING THE DEVELOPMENT AND PROGRESSION OF CANCER.NATURE REVIEWS CANCER. VOL. 14. ISSUE 1. P. 13 -25 | 103 | 74% | 72 |
9 | BOKOCH, GM , (2003) BIOLOGY OF THE P21-ACTIVATED KINASES.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 72. ISSUE . P. 743-781 | 136 | 62% | 676 |
10 | BERG, LJ , FINKELSTEIN, LD , LUCAS, JA , SCHWARTZBERG, PL , (2005) TEC FAMILY KINASES IN T LYMPHOCYTE DEVELOPMENT AND FUNCTION.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 23. ISSUE . P. 549 -600 | 151 | 73% | 175 |
Classes with closest relation at Level 2 |
Rank | Class id | link |
---|---|---|
1 | 1911 | FARNESYLTRANSFERASE//RAS//RAL |
2 | 2228 | C MYB//B MYB//SRC |
3 | 1220 | PTEN//MTOR//COWDEN SYNDROME |
4 | 3948 | SPROUTY//LRIG1//MIG 6 |
5 | 3960 | IMP3//DLC1//DELETED IN LIVER CANCER 1 |
6 | 2254 | PHOSPHOLIPASE D//DIACYLGLYCEROL KINASE//PHOSPHATIDIC ACID |
7 | 2998 | RGS PROTEINS//GIRDIN//RGS |
8 | 1452 | CHRONIC MYELOID LEUKEMIA//IMATINIB//NILOTINIB |
9 | 3713 | A20//LAPTM4B//WWP1 |
10 | 1195 | JNK//ERK5//MAP KINASE |